Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer (Q72526588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

main subject

metastatic breast cancer

1 reference

J. G. Klijn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6122975

9 August 2023

F. H. de Jong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6122975

9 August 2023

language of work or name

English

0 references

publication date

1 May 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

29 May 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6122975

full work available at URL

9 August 2023

https://api.elsevier.com/content/article/PII:S014067368292339X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92339-X

https://api.elsevier.com/content/article/PII:S014067368292339X?httpAccept=text/plain

9 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92339-X

9 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

1213-1216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

Hypothalamic-pituitary-testicular function in rats after supraphysiological doses of a highly active LRH analogue (buserelin)

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Induction of Luteolysis in the Human with a Long-Acting Analog of Luteinizing Hormone-Releasing Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Histological and endocrine studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

The importance of pituitary tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Effects of a luteinizing hormone-releasing hormone analog and tamoxifen on the growth of an estrogen-induced prolactin-secreting rat pituitary tumor and its influence on pituitary gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Extrapituitary Action of Gonadotropin-Releasing Hormone: Direct Inhibition Ovarian Steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Gonadotropin-Releasing Hormone: Regulation of Adenosine 3′,5′-Monophosphate in Ovarian Granulosa Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992339-X

7 January 2021

Possible Luteolytic Effects of Luteinizing Hormone-Releasing Hormone in Normal Women

series ordinal

7

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92339-X

Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing Hormone

9 August 2023

series ordinal

15

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92339-X

9 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6122975%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference